Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Total Debt: 2011-2012

Historic Total Debt for Sonoma Pharmaceuticals (SNOA) over the last 2 years, with Dec 2012 value amounting to $1.6 million.

  • Sonoma Pharmaceuticals' Total Debt fell 51.82% to $1.6 million in Q4 2012 from the same period last year, while for Dec 2012 it was $1.6 million, marking a year-over-year decrease of 86.14%. This contributed to the annual value of $3.2 million for FY2012, which is 27.27% up from last year.
  • Per Sonoma Pharmaceuticals' latest filing, its Total Debt stood at $1.6 million for Q4 2012, which was down 41.07% from $2.6 million recorded in Q3 2012.
  • Sonoma Pharmaceuticals' 5-year Total Debt high stood at $3.2 million for Q1 2012, and its period low was $1.6 million during Q4 2012.
  • Its 2-year average for Total Debt is $2.7 million, with a median of $2.8 million in 2011.
  • Within the past 5 years, the most significant YoY rise in Sonoma Pharmaceuticals' Total Debt was 27.27% (2012), while the steepest drop was 51.82% (2012).
  • Over the past 2 years, Sonoma Pharmaceuticals' Total Debt (Quarterly) stood at $3.2 million in 2011, then plummeted by 51.82% to $1.6 million in 2012.
  • Its last three reported values are $1.6 million in Q4 2012, $2.6 million for Q3 2012, and $2.9 million during Q2 2012.